Advisory board to provide guidance for company’s eosinophilic esophagitis clinical program VICTORIA, BC – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its… Read More
BOSTON, MA & VANCOUVER, BC — Alpha-9 Oncology (Alpha-9), a clinical stage company developing radiopharmaceuticals for the treatment of cancer patients worldwide, announced that the first participant has been dosed… Read More
In May, Lithuania marks 20 years of European Union membership. The Baltic country is keen to develop its global presence in the life-science and biotechnology sectors by retaining home-grown talent,… Read More
ROCKVILLE, MD & EDMONTON, AB – In recognition of Lupus Awareness Month, Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), announced several initiatives to improve understanding of the seriousness… Read More
VANCOUVER, BC – AbCellera (Nasdaq: ABCL), Viking Global Investors (“Viking”), and ArrowMark Partners (“ArrowMark”) announced that they have entered into a collaboration to advance new antibody drug programs with an aim to launch multiple… Read More
